Active	Status	Sponsor type	Region	Phase	Filter
13 Active 3 Inactive 16 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

13 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Trebicka, Jonel
CARP, NCT05551299: Treatment of Non-resectable Bile Duct Cancer With Radiofrequency Ablation or Photodynamic Therapy	Recruiting	4	258	Europe	Photosensitizer, Photodynamic therapy (PDT), Radiofrequency ablation (RFA)	University of Leipzig, Zentrum für Klinische Studien Leipzig	Hilar Cholangiocarcinoma	04/28	04/28
PRECIOSA, NCT03451292 / 2016-001789-28: Effects of Long-Term Administration of Human Albumin in Subjects With Decompensated Cirrhosis and Ascites	Completed	3	410	Europe, Canada, US, RoW	Albutein 20% Injectable Solution, Standard medical treatment	Grifols Therapeutics LLC, Instituto Grifols, S.A.	Decompensated Cirrhosis and Ascites	05/24	05/24
NCT04950127 / 2021-000007-21: Global Linerixibat Itch Study of Efficacy and Safety in Primary Biliary Cholangitis (PBC) (GLISTEN)	Active, not recruiting	3	238	Europe, Canada, Japan, US, RoW	Linerixibat, Placebo	GlaxoSmithKline	Pruritus	10/24	01/25
NCT05056220: Personalized Long-term Human Albumin Treatment in Patients With Decompensated Cirrhosis and Ascites	Recruiting	3	240	Europe	Human albumin, sodium chloride	Aleksander Krag, EASL - CLIF Consortium	Decompensated Cirrhosis and Ascites	03/25	04/25
APACHE, NCT03702920 / 2016-001787-10: Short-term Survival of Subjects With Acute-on-chronic Liver Failure After Plasma Exchange With Human Serum Albumin 5%	Recruiting	3	380	Europe, US	SMT + PE-A 5%, Albutein 5%, Standard Medical Treatment, SMT	Grifols Therapeutics LLC, Instituto Grifols, S.A.	Acute-On-Chronic Liver Failure	10/26	10/26
LLSAT, NCT04167358 / 2019-003158-10: Linerixibat Long-term Safety, and Tolerability Study	Recruiting	3	251	Europe, Canada, Japan, US, RoW	Linerixibat	GlaxoSmithKline, GlaxoSmithKline LLC, GlaxoSmithKline Research & Development Limited	Cholestasis	02/27	02/27
COMBAT, NCT05895136: A Novel COMBinATorial Therapy With Albumin and Enoxaparin in Patients With Decompensated Cirrhosis at High-risk of Poor Outcome ( Trial).	Recruiting	2	90	Europe	Human albumin, Enoxaparin, Standard medical treatment	European Foundation for Study of Chronic Liver Failure	Liver Cirrhosis	03/25	03/25
DETECT, NCT06523608: Prediction of Decompensation and HCC Development in Advanced Chronic Liver Disease	Recruiting	N/A	600	Europe	Standard survillance protocol, Stratified survillance protocol	University Hospital Muenster	Liver Diseases, Hepatocellular Carcinoma, Hepatocarcinoma, Advanced Chronic Liver Disease	09/25	09/27
Liver-HERO, NCT05346393: HRS-AKI Treatment With TIPS in Patients With Cirrhosis	Recruiting	N/A	124	Europe	TIPS, Standard of Care, Terlipressin + Albumin	Jena University Hospital, German Research Foundation, University Hospital Halle (Saale)	Cirrhosis, Liver, Hepatorenal Syndrome, Acute Kidney Injury, Ascites Hepatic	06/25	06/26
NCT03584204: Skeletal Muscle Parameters of Liver Cirrhosis in Non-invasive Imaging and Outcome	Recruiting	N/A	400	Europe	imaging	University Hospital, Bonn, University of Roma La Sapienza	Liver Cirrhosis	07/25	08/26
ACLF-I, NCT04975490: Characterization and Pathogenesis of ACLF	Recruiting	N/A	1000	Europe		Johann Wolfgang Goethe University Hospital	Liver Cirrhosis, Acute-On-Chronic Liver Failure, Portal Hypertension	09/25	12/25
CHANCE, NCT04613921: Liver Transplantation in Patients With CirrHosis and Severe Acute-on-Chronic Liver Failure: iNdications and outComEs	Recruiting	N/A	3000	Europe, Canada, Japan, US, RoW	Observational Protocol	European Foundation for Study of Chronic Liver Failure	Liver Diseases, Liver Cirrhosis, Acute-On-Chronic Liver Failure, Liver Transplant; Complications	12/25	12/26
NCT05661331: VIATORR Device Registry	Recruiting	N/A	196	Europe	Transjugular intrahepatic portosystemic shunt, TIPS	W.L.Gore & Associates	Chronic Liver Disease	01/25	01/28